IL1B and Insulin resistance: A previous observational study demonstrated that a combined elevation of IL-1β and IL-6 was associated with a roughly threefold increased risk of T2DM, and IL-1β might induce insulin resistance via activating the IκB kinaseβ (Spranger et al., 2003).